This year’s Annual bioProcessUK Conference will centre on the theme “Processing priorities for the future”.
The programme will be made up of keynote presentations, panel discussions, poster flashes, workshops, one-to-one speed partnering and the networking dinner.
Why should you be there?
- Expected attendance of 300+ delegates from the biological medicines sector in the UK and abroad
- Learn about the changing face of bioprocessing to deliver future medicines
- Meet the talent of tomorrow through the student bursary programme
- Network and…
November 7–9, 2016
KoelnMesse - Congress Center North,
ACCESS A WORLD OF OPPORTUNITIES THROUGH LIFE SCIENCE PARTNERING AT BIO-EUROPE
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.
Visit us at the UK Delegation Booth 55.
For more information or to register, please visit; https://ebdgroup.knect365.com/bioeurope
Join us at this years' World ADC event in San Diego - Uniting Scientists from Across the ADC Community.
If you’re working with ADCs this is a must attend conference.
It will address your most pressing challenge – how do we develop more clinically effective ADCs?
Focussed on ADCs and crafted with the field’s thought-leaders, World ADC is the industry’s definitive forum for learning and networking.
For more information or to register for the event - visit the World ADC website…
Glythera’s Senior Development Scientist Dr Christopher Birchall will attend the Containment of highly potent APIs masterclass held in London, 17 March 2015.
Five years ago the drivers for containment was almost strictly for protecting the operators for exposure of the compound, equally important, appreciation of containing the product so the risk of cross contamination in the facility. This Masterclass will assess how to improve understanding on containment and identifying how to minimise the risks of exposure.
Glythera’s CEO Dr David Simpson will attend the USA Market Visit held in Boston, 2/5 December 2014.
- Receive briefings on the US and New England business environments
- Gain insight into what it takes to develop business in the Northeast US
- Experience a thriving information technology, education, finance, professional services, life sciences, energy and environment, and R&D mega-hub
- Build connections with industry and innovation leaders, buyers and vendors
- Meet leading companies across greater Boston, networking…
We're pleased to announce Dr David Simpson as a speaker at the 11th Annual bioProcessUK Conference. The annual bioProcessUK conference, now organised by the BIA is a two day event taking place on 25-26 November 2014 at St Geroge’s Hall in Liverpool.
- Expected attendance is between 250 – 275 from the biological medicines sector in the UK and abroad
- Learn about the latest strategic and technical developments taking place and gain insight into the global biological medicines…
Glythera’s Senior Development Scientist Dr Justyna Mysliwy and our Development Chemist Dr David Mansell will attend the Waters ADC 2014 Meeting held in Waters MS Headquarters - Wilmslow, 20/21 November 2014.
Waters ADC 2014 meeting consists of a mixture of presentations, round-table discussions and laboratory demonstrations so attendees can tailor the agenda to suit themselves. This meeting is relevant for scientists using LC and LC/MS to analyze and characterize ADCs.
Please find more information at Waters website.
Glythera’s Senior Development Scientist Dr Christopher Birchall will attend the Autumn Symposium 2014 held in Manchester, 19/20 November 2014.
Today’s safety professional has to work in an ever-changing world. The Autumn Symposium 2014 will take time out to examine in depth the significant changes affecting the way we work and the time frame for the changes to be implemented.
Glythera’s CEO Dr David Simpson will attend FT Global Pharmaceutical and Biotechnology conference 2014 taking place on 17-18 November at the Marriott Grosvenor, London.
The future is arriving fast for the life science industry. Convergence is happening along the entirety of the industry value chain, blurring the boundaries between pharma, biotech, genetics, devices and broader healthcare companies. The FT Global Pharmaceutical and Biotechnology Conference will bring together senior level executives and corporate decision-makers from around the world to discuss what the life science company…
Glythera’s HR & Office Manager Filipa Sequeira will attend the CIPD Annual Conference and Exhibition held in Manchester Central (formerly GMEX), 5/6 November 2014.
The CIPD Annual Conference and Exhibition is the one event in the year that you cannot afford to miss! Whether you’re looking to develop your workforce, manage an OD strategy, retain your talent or evaluate your recruitment processes, we’ve got the solutions you need to create high impact HR.
Please find more information at the conference website:…
Glythera’s CEO Dr David Simpson and our Commercial Director Dr Ian Evetts will attend BIO-Europe conference held in Frankfurt - Germany, 3 – 5 November 2014.
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.
Glythera’s Technical Director Dr Jenny Thirlway will attend PEGS Europe held in the Lisbon Marriott Hotel, 3/7 November 2014.
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With two consecutive years of 40% growth in attendance, and another year of expanded program coverage, this year’s event will feature:
- 500 attendees
- 150 technical presentations
- 100+ scientific posters
- 40+ sponsors & exhibitors
- Dedicated networking opportunities
- Exclusive exhibit & poster hours
- Interactive roundtable, breakout & panel discussions
Glythera’s CEO Dr David Simpson, our Technical Director Dr Jenny Thirlway and our Commercial Director Dr Ian Evetts will attend World ADC held in San Diego – USA, 26/29 October 2014.
World ADC San Diego has been designed to dramatically enhance ADC research and development efforts. Providing access to expert intelligence on how to select lead candidate with confidence, improve preclinical predictability and maximize clinical efficacy.
Please find more information at Hanson Wade website: adc-summit.com
Glythera’s Technical Director Dr Jenny Thirlway will attend 1ST Annual Biopronet Scientific Symposium held in Cardiff, 23 – 24 October 2014.
The BioProNET network (a BBSRC NIBB co-sponsored by EPSRC) covers the field of bioprocessing and biologics. BioProNET engages academics, industrialists and other special interest groups to accelerate innovation and deliver change. BioProNET aims to ensure that the UK academic research agenda is world-leading and industrially relevant. The network launched in early 2014 and is promoting the research area through…
Glythera’s CEO Dr David Simpson will attend the Venturefest North East 2014 taking place tomorrow – 21st October at the Hilton Newcastle-Gateshead.
Venturefest North East is a full-day event focussing on how businesses can embrace innovative thinking, designed to bring together businesses, corporates, investors, academics and advisors with specific expertise in innovation.
The programme includes the chance to hear from high profile speakers and take part with in-depth workshops and one-to-one coaching sessions from industry innovation experts. With the opportunity to pitch…
Glythera’s CEO David Simpson will attend UK Bioscience Forum held in London, 07 October 2014.
This year’s award-winning UK Bioscience Forum, taking place during European Biotech week will showcase day's panel sessions, industry-leading speakers, speed-partnering, exhibition hall and extensive networking
Please find more information at BIA website: ukbioscienceforum
Glythera’s Senior Development Scientist Justyna Mysliwy will attend the Antibody-Drug Conjugates Seminar taking place on 6th October 2014, Oxford.
Benefits to Attending - Gain a comprehensive overview of the Antibody Drug Conjugate industry; look at major developments thus far, discover which companies are driving innovation in the field and explore how ADCs function.
Please find more information at oxfordglobaltraining
Glythera’s CEO Dr David Simpson will participate as STEM ambassador in the Oxclose Community Academy's Careers Fayre taking place tomorrow (3RD October) at the Oxclose Community Academy, Washington.
The year 11 Careers Fayre will have many providers representing their organisation. Half of the year group (100 pupils) will come around in two separate sessions and speak with the various providers and ask questions so that they are better informed about the options and future opportunities open to them.
Glythera’s CEO David Simpson will attend Biocap conference held in Deansgate – Manchester, 29 Sept 2014.
BioCap is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of life science investment opportunities.
Please find more information at Bionow website: bionow.co.uk
Glythera's Development Chemist Dr David Mansell will attend the Scalling from Milligrams to 1-2kg training course held in Nice-France, 22-24 September 2014.
The aim of the course is to provide a good basis to work from when involved in taking development candidates to the first in human trials with a view also on some longer-term requirements. The course content will therefore focus on the necessary early phases of chemical development as would typically be required to support production of up…
Glythera’s CEO David Simpson will attend UK CEO and Investor Forum 2014 place on Thursday 10 and Friday 11 July at Lingfield Park, Surrey.
With high-level networking this exclusive residential event for senior management will start with an evening networking drinks and dinner discussion on the public markets and showcase recent successes. The following day interactive discussion sessions will cover the very latest updates on early access, adaptive licensing, plus an update on the 2015-2020 BIA Manifesto. Other sessions will…
Glythera’s Technical Director Jenny Thirlway was invited to present An introduction to ADCs at 2014 EU BSN Meeting – Merck Millipore. The meeting took place on June 24th, 2014 at La Petite Pierre in France.
Glythera's HR & Office Manager Filipa Sequeira will participate in Biology careers school event on 19 of June 2014 at York University.
This career school event aims to help future graduates to discover their true career path.
Glythera Technical Director Jenny Thirlway will attend the Antibody Drug Conjugates congress on 18 & 19 June 2014 at the Crowne Plaza Barcelona Fira Center, Spain.
With ADCs estimated to be worth $9 Billion in the next 10 years, never has it been so important to develop effective production platforms and highly targeted products to ensure a niche product in an increasingly competitive market. So this congress will offers a highly technical, yet strategic conference addressing the industry's most pressing development…
Glythera’s Senior Development Scientist Christopher Birchall will attend the Cells, Proteins and Bioprocessing conference on 18 of June 2014 at the Cineworld, London.
This three day event will discuss three main topics:
- Cell Culture Technology Event: Recent advances, future prospect
- Therapeutic proteins and antibodies: from design to function
- Bioprocess development: Discussing facilitation of industrial uptake
Please find more information at lifescienceevents.com
Glythera’s Technical Director Jenny Thirlway was invited to present a CV Workshop, taking place in Newcastle University on June 12th, 2014.
Please find more information at Newcastle University website.
Glythera’s Development Scientists Christopher Birchall and Justyna Mysliwy will attend the SGS UK Biopharma day on 5 June 2014 at the Cambridge Science Park, UK.
During this one-day seminar it will be discuss the advances in Biopharmaceutical development of antibody, fragment and bioconjugate based therapeutics. Experts will be on hand to discuss, market trends, characterisation, product integrity, stability, and biosafety of modern biotherapeutics. The day will include a selection of scientific talks, case studies and face-to-face meetings.
Please find more…
Glythera’s Technical Director Jenny Thirlway was invited to attend the BioProNET Sandpit, taking place in Manchester on June 4th- 5th, 2014.
Objectives of meeting – development of applications for BBSRC NIBB Proof-of Concept research grants and Business Interaction Vouchers, IB Catalyst research grant applications and other large-scale responsive mode grant initiatives.
Please find more information at biopronetuk.org
Glythera’s Commercial Director Ian Evetts will attend ASCO Annual Meeting | Science & Society on May 30 - June 3, 2014 at McCormick Place Chicago, Illinois.
The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society."
Please find more information at ASCO website
Glythera Technical Director Jenny Thirlway will attend the 7th Annual Proteins and Antibodies Congress on 3rd & 4th April 2014 at the Novotel London West, UK.
Over two days, this meeting will bring together over 400 senior-level decision makers working at the forefront of the proteins and antibodies field in Europe and the US. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.…
Glythera Chief Operating Officer David Simpson will attend the BIO-Europe Spring® 2014 conference that will be held in Turin, Italy, 10th - 12th March 2014 at the Oval Lingotto.
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high calibre partnering opportunities.
IO-Europe Spring annually attracts top international executives from:
- Established and emerging biotech companies
- Pharmaceutical companies
- Academic innovators
- Private investors including venture capital and private…
Our Commercial Director Ian Evetts and Principal Scientist, Jenny Thirlway will be attending the World ADC Frankfurt conference in Frankfurt, Germany, 17th - 20th February 2014.
World ADC Frankfurt is the European forum for ADC developers to learn, network and discuss how to achieve these goals. Working with pioneers from Pfizer, Roche, Genentech, Bayer, Seattle Genetics, ImmunoGen and Novartis, the world class speaker line-up will discuss issues focussed on target discovery, payload/linker stability, analytical characterisation and clinical development.
Please find more information at http://adcsummit-europe.com/
Our Principal Scientist, Jenny Thirlway will be attending the University of Sheffield Industry Day - Chemical and Biological Engineering in Sheffield, Thursday 6 February 2014. Research areas to be presented include mammalian and microbial bioprocessing, cutting edge analytics and postgenomics technology, protein engineering, and process and metabolic modelling.
Please find more information at http://www.shef.ac.uk/cbe
Enterprise Europe Network in Scotland will host the Life Sciences Scotland Partnering & Horizon 2020 Consortia Building Workshop Event 2014. Taking place Thursday, 6th of February 2014 at the Caledonian Waldorf Astoria, Edinburgh.
This annual Scottish showcase event provides an ideal platform to explore potential partnerships so our Chief Operating Officer David Simpson will attend this event. Companies from across the world including Finland, Germany, Italy, Republic of Ireland, and the USA will probably attend this event as they did…
Our Chief Operating Officer Dave Simpson will attend the BioSynergy Conference - Partnering for Success that will be held in The Food and Environment Agency (FERA), Sand Hutton, York on Wednesday 29th January 2014.
The inaugural BioSynergy Conference, will bring together businesses, academia and experts in the life sciences community. This conference will attract delegates from across the region, the UK and abroad, will bring presentations from key leaders within the sector and will promote opportunities to participate in one-to-one…
Glythera Principal Scientist Jenny Thirlway will make a presentation on ESACT-UKs 24th Annual Meeting in 8-9 January 2014 at Nottingham Belfry (Q Hotels).
Based in the United Kingdom, ESACT-UK is a Society which promotes the communication of knowledge and experience between scientists and engineers whose work has a direct or indirect bearing on cell culture biotechnology and the products derived from it.
This meeting is an annual two-day scientific meeting that is held in January each year, and include additional workshops,…